Related Experiment Video
Updated: Jul 12, 2026

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
Use of multiple sclerosis drugs among pregnant individuals with live-birth deliveries in the FDA's Sentinel
Danijela Stojanovic1, Lockwood Taylor1, Mayura Shinde2
1U.S. Food and Drug Administration, Silver Spring, MD, USA.
Background:
Administrative claims databases may complement pregnancy registries for post-marketing utilization assessment and safety surveillance.
Objective:
To assess patterns of utilization of disease-modifying therapies (DMT) indicated for treatment of multiple sclerosis among women with live-birth deliveries across pregnancy and over time.
Methods:
We conducted a retrospective administrative claims-based utilization analysis from January 1, 2001, to December 31, 2020 in the Sentinel Distributed Database. We described use across the pregnancy period and over time among pregnancies ending in a live-birth delivery and matched non-pregnant episodes.
Results:
Among 2,142,706 pregnancies resulting in live-birth deliveries, 1,362 pregnancies were exposed to DMTs (< 0.1%). Glatiramer acetate was the most prevalent DMT any time in pregnancy (48.9%), followed by interferon beta 1a (22.4%), dimethyl fumarate (10.7%), and natalizumab (8.4%). The highest use was observed six months prior to pregnancy start, while the lowest use was in the second trimester.
Conclusions:
In our analysis, exposure to DMT was low and varied across the pregnancy period. Use among pregnant patients was highest in the six months prior to pregnancy start and remained lower than pre-pregnancy levels after delivery.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Multiple Sclerosis l: Introduction
Factors Affecting Drug Response: Overview
Intrauterine Drug Delivery Systems
Factors Affecting Drug Distribution: Physiological Barriers
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
